Jauns pētījums ierosina, ka nabassaites audus kādu dienu varētu lietot, lai ārstētu hroniskas, neārstējamas diabētiķu pēdu čūlas. EpiCord ir biezas membrānas produkts, kas radīts no nabassaites, tas ir izpētīts un pārbaudīts kā ievainojumu nosegšanas forma un čūlu ārstēšanas forma.
A new study suggests that umbilical cord tissue could one day be used to treat chronic, non-healing diabetic foot ulcers. EpiCord, a thick membrane product produced from umbilical cords, has been studied and tested as a form of wound dressing and healing for the ulcers.
A joint US and Chinese clinical trial has successfully demonstrated dental tissue regrowth using stem cells from baby teeth. The Phase 1 trial suggests a promising solution to injury-caused tooth damage in children with young adult teeth.
Researchers at the Stowers Institute of Medical Research have found another way to expand/multiply blood-forming, adult stem cells from umbilical cord blood. The discovery increases the potential of a single stem cell sample in treating more conditions.
Pioneering research by University of Adelaide could offer a huge step forward to treating patients with cystic fibrosis (CF). The research shows that the cells causing the genetic disorder could be replaced with healthy cells.
